Página Nct de ensaios clínicos
Clinical Trial Results:
M48P3: A phase IV, randomized, controlled, single-blind, multi-center study in children to evaluate the safety, tolerability and immunogenicity of two TBE vaccines administered according to two different schedules
| Summary | |
EudraCT number | 2004-003616-37 |
Trial protocol | DE |
Global completion date | 19 Jul 2006 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | Yes |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 20 Jan 2019 |
First version publication date | 20 Jan 2019 |
Other versions | |
Summary report(s) | M48P3 results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.